Viewing nowCombinationLipitor Plus Tablet 10/40 mg
Atorvastatin Calcium Trihydrate 43.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Jeil Pharmaceutical Co., Ltd.

MFDS item code 202101398 · Approved 2021.02.18 · Insurance code 645405810
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed dyslipidemia
This drug is used as an adjunct to dietary therapy to lower total cholesterol, LDL-cholesterol, apo B, triglycerides, and non-HDL-cholesterol levels in patients with primary hypercholesterolemia and mixed dyslipidemia, while increasing HDL-cholesterol levels. It can also be administered alone or in combination with other lipid-lowering treatments in patients with homozygous familial hypercholesterolemia. This drug is used alongside dietary regulation to reduce the risk of atherosclerotic vascular disease due to dyslipidemia, considering and treating other secondary causes as well. Caution is necessary in patients with high cardiovascular risk, and monitoring and management of lipid levels are important. Overall, this drug helps effectively improve blood lipid abnormalities.
Administer this medication once daily, regardless of meals. Patients should continue a standard cholesterol-lowering diet before and during treatment with this medication. The dose of this medication should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dose range of this medication is 10/10mg∼10/80mg once daily. The recommended initial dose is 10/10mg or 10/20mg once daily. For patients who require a greater reduction in LDL cholesterol (55% or more), the recommended initial dose is 10/40mg once daily. After starting this medication or adjusting the dose, check serum lipid levels at intervals of at least 2 weeks and adjust the dose accordingly. Homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg or 10/80mg once daily. Administer this medication as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful.
This drug may cause abnormal reactions in muscles; if symptoms like muscle pain or weakness occur, inform your doctor immediately. Rhabdomyolysis, a severe muscle injury, has been reported rarely. If risk factors such as kidney impairment, severe infection, hypotension, or post-major surgery are present, treatment should be discontinued or paused. This drug may affect liver function, so regular liver function tests should be conducted before and during treatment. If liver damage symptoms appear, consult your doctor immediately. Patients with liver disease or persistent unexplained elevated liver enzymes should not use this drug. Co-administration with certain other medications may increase the risk of muscle abnormal reactions; inform your doctor or pharmacist if you are taking other medicines. Women who are pregnant or may become pregnant, and nursing mothers should not take this medicine, and women of childbearing age should use appropriate contraception during treatment. Patients with a history of excessive alcohol intake or liver disease, the elderly, and those with impaired kidney function should use this drug with caution and require regular check-ups. Dizziness or drowsiness may occur, so caution is needed when driving or operating machinery. Safety in children has not been established, so it is not recommended. There is no specific antidote for overdose; appropriate treatment and monitoring of liver function and muscle-related tests should be conducted according to symptoms.
Not everyone experiences these, and they can vary from person to person.
This drug may be sensitive to air or moisture, so it should be stored in a tightly closed container. It is advisable to maintain storage temperatures between 1 and 30 degrees Celsius. By storing it this way, the effectiveness of the drug can be maintained for a longer period.
White to off-white, capsule-shaped, film-coated tablet with a biconvex appearance, engraved with 'JI 40' on one side.
30 tablets/PTP [30 tablets (10 tablets/PTP x 3)], 30 tablets/bottle, 90 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAtorvastatin Calcium Trihydrate 43.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Jeil Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 86.8mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 10.9mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationAtorvastatin Calcium 10.85mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
CombinationAtorvastatin Calcium 21.7mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
CombinationAtorvastatin Calcium 43.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.